CANC ETF

CANC ETF
$40.58
See how much of CANC you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

RVMD is CANC's largest holding at 5.55% of the fund as of Sep 14, 2026. CANC is Tema Oncology ETF.

Showing top 50 of 59 holdings · as of Sep 14, 2026
CANC holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
RVMD
Revolution Medicines IncHealth Care · Biotechnology
5.55%		5.5%55,664$11.42MHealth CareBiotechnology
2
COGT
Cogent Biosciences IncHealth Care · Biotechnology
4.99%		10.5%307,451$10.27MHealth CareBiotechnology
Sector and industry · Pro
3
MRK
Merck & Company Inc
4.68%		15.2%66,469$9.63M
4
LLY
Eli Lilly & Co.
4.54%		19.8%8,209$9.34M
5
NVS
Novartis Ag -
3.63%		23.4%53,535$7.46M
6
BMY
Bristol-Myers Squibb Co.
3.59%		27.0%115,234$7.39M
7
ABBV
AbbVie Inc.
3.55%		30.5%27,898$7.30M
8
BGNE
BeOne Medicines Ltd. Sponsored Adr (1 Ads : 13 Ordinary)
3.28%		33.8%19,049$6.74M
9
JNJ
Johnson & Johnson -
3.24%		37.0%25,055$6.67M
10
RHHBY
Roche Holding Ag (Adr)
3.18%		40.2%119,440$6.55M
11
HALO
Halozyme Therapeutics Inc
3.07%		43.3%58,493$6.31M
12—Genmab A/s ADR
2.97%		46.3%187,107$6.11M
13
CGON
Cg Oncology Inc
2.84%		49.1%79,127$5.84M
14
EXEL
Exelixis Inc
2.83%		51.9%103,531$5.82M
15
IMNM
Immunome Inc
2.81%		54.8%235,688$5.79M
16
IDYA
Ideaya Biosciences Inc
2.68%		57.4%145,181$5.52M
17
BBIO
Bridgebio Pharma Inc_None_0
2.60%		60.0%73,889$5.35M
18
ELVN
Enliven Therapeutics Inc
2.60%		62.6%98,433$5.36M
19
ERAS
Erasca Inc.
2.11%		64.7%269,242$4.35M
20—AstraZeneca PLC
2.11%		66.9%26,513$4.35M
21
RLAY
Relay Therapeutics Inc
2.08%		68.9%224,406$4.28M
22
ZLAB
Zai Lab Ltd
1.97%		70.9%164,578$4.05M
23
LEGN
Legend Biotech Corp
1.82%		72.7%201,984$3.74M
24
CELC
Celcuity Inc
1.77%		74.5%43,707$3.65M
25
IOVA
Iovance Biotherapeutics Inc
1.74%		76.2%386,437$3.58M
26—Zymeworks Inc.
1.47%		77.7%112,869$3.03M
27
SMMT
Summit Therapeutics
1.37%		79.1%153,105$2.82M
28
URGN
Urogen Pharma Ltd Com Ils0.01
1.30%		80.4%62,529$2.67M
29
NUVB
Nuvation Bio Inc
1.23%		81.6%425,168$2.53M
30
AMGN
Amgen Inc.
1.21%		82.8%6,542$2.50M
31
FXFXX
First Am Treas Obli-X
1.21%		84.0%2,490,212$2.49M
32
GILD
Gilead Sciences
1.06%		85.1%14,946$2.19M
33
RCUS
Arcus Biosciences Inc
1.04%		86.1%88,847$2.14M
34
NTRA
Natera Inc
1.03%		87.1%6,204$2.12M
35
KURA
Kura Oncology Inc
0.98%		88.1%174,895$2.02M
36
CRVS
Corvus Pharmaceuticals Inc
0.93%		89.1%145,642$1.91M
37
ANAB
Anaptysbio Inc
0.88%		89.9%33,414$1.81M
38
INBX
Inhibrx Biosciences Inc
0.77%		90.7%14,407$1.59M
39
IMTX
Immatics Nv
0.77%		91.5%183,297$1.58M
40
GH
Guardant Health, Inc
0.73%		92.2%8,943$1.50M
41—Immunocore Holdings Ltd Adr
0.72%		92.9%45,820$1.49M
42
ORIC
Oric Pharmaceuticals, Inc. Series C
0.70%		93.6%113,079$1.43M
43
REPL
Replimune Group Inc
0.70%		94.3%110,633$1.45M
44
TNGX
Tango Therapeutics Inc.
0.68%		95.0%56,944$1.40M
45—Cullinan Oncology Inc
0.67%		95.7%67,125$1.37M
46
TYRA
Tyra Biosciences Inc
0.66%		96.3%54,092$1.36M
47
ANL
Amani Gold Ltd
0.58%		96.9%75,283$1.20M
48
SNDX
Syndax Pharmaceuticals Inc
0.50%		97.4%56,082$1.03M
49
CADL
Candel Therapeutics Inc.
0.46%		97.9%88,097$940.4K
50
JANX
Janux Therapeutics Inc
0.46%		98.3%55,053$953.0K
More holdings · Pro
Not reported for this fund: share changes.
FundXLS Pro
See the other 9 holdings of CANC
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

CANC ETF All Holdings

CANC holdings total 118 positions. The top 10 holdings account for 40.2% of the fund, led by Revolution Medicines Inc at 5.5%, Cogent Biosciences Inc at 5.0%, Merck & Company Inc at 4.7%.

CANC portfolio concentration is moderate, with the top 10 representing 40.2% of total assets. The largest sector exposure is Health Care at 90.2%.

CANC sectors provide a detailed breakdown. CANC overlap shows how holdings compare to other funds in your portfolio.

Compare CANC

CANC vs SPYCANC vs QQQCANC vs VOOCANC vs VTICANC vs IVVCANC vs SCHDCANC vs VYMCANC vs VXUS

CANC ETF Holdings

59 of 118 holdings

  • 1

    Revolution Medicines Inc

    RVMDHealth Care
    5.55%
  • 2

    Cogent Biosciences Inc

    COGTHealth Care
    4.99%
  • 3

    Merck & Company Inc

    MRKHealth Care
    4.68%
  • 4

    Eli Lilly & Co.

    LLYHealth Care
    4.54%
  • 5

    Novartis Ag - Common

    NOVN:SMUnknown
    3.63%
  • 6

    Bristol-Myers Squibb Co.

    BMYHealth Care
    3.59%
  • 7

    Abbvie Inc.

    ABBVHealth Care
    3.55%
  • 8

    BeOne Medicines Ltd. Sponsored Adr (1 Ads : 13 Ordinary)

    BGNE:SHHealth Care
    3.28%
  • 9

    Johnson & Johnson - Common

    JNJHealth Care
    3.24%
  • 10

    Roche Holding Ag (Adr)

    RHHBY:SMUnknown
    3.18%
  • 11

    Halozyme Therapeutics Inc

    HALOHealth Care
    3.07%
  • 12

    Genmab A/s ADR

    GMAB:COHealth Care
    2.97%
  • 13

    Cg Oncology Inc

    CGONHealth Care
    2.84%
  • 14

    Exelixis Inc

    EXELHealth Care
    2.83%
  • 15

    Immunome Inc

    IMNMHealth Care
    2.81%
  • 16

    Ideaya Biosciences Inc

    IDYAHealth Care
    2.68%
  • 17

    Bridgebio Pharma Inc_None_0

    BBIOHealth Care
    2.60%
  • 18

    Enliven Therapeutics Inc

    ELVNHealth Care
    2.60%
  • 19

    Erasca Inc.

    ERASHealth Care
    2.11%
  • 20

    AstraZeneca PLC

    AZN:LNUnknown
    2.11%
  • 21

    Relay Therapeutics Inc

    RLAYHealth Care
    2.08%
  • 22

    Zai Lab Ltd

    ZLABHealth Care
    1.97%
  • 23

    Legend Biotech Corp

    LEGNHealth Care
    1.82%
  • 24

    Celcuity Inc Com

    CELCHealth Care
    1.77%
  • 25

    Iovance Biotherapeutics Inc

    IOVAHealth Care
    1.74%
  • 26

    Zymeworks Inc. Common Stock

    ZYME:CAHealth Care
    1.47%
  • 27

    Summit Therapeutics

    SMMTHealth Care
    1.37%
  • 28

    Urogen Pharma Ltd Com Ils0.01

    URGNHealth Care
    1.30%
  • 29

    Nuvation Bio Inc

    NUVBHealth Care
    1.23%
  • 30

    Amgen Inc.

    AMGNHealth Care
    1.21%
  • 31

    First Am Treas Obli-X

    FXFXXFinancials
    1.21%
  • 32

    Gilead Sciences

    GILDHealth Care
    1.06%
  • 33

    Arcus Biosciences Inc

    RCUSHealth Care
    1.04%
  • 34

    Natera Inc

    NTRAHealth Care
    1.03%
  • 35

    Kura Oncology Inc

    KURAHealth Care
    0.98%
  • 36

    Corvus Pharmaceuticals Inc

    CRVSHealth Care
    0.93%
  • 37

    Anaptysbio Inc

    ANABHealth Care
    0.88%
  • 38

    Inhibrx Biosciences Inc

    INBXHealth Care
    0.77%
  • 39

    Immatics Nv

    4A3:BEHealth Care
    0.77%
  • 40

    Guardant Health, Inc

    GHHealth Care
    0.73%
  • 41

    Immunocore Holdings Ltd Adr

    IMCR:LNHealth Care
    0.72%
  • 42

    Oric Pharmaceuticals, Inc. Series C

    ORICHealth Care
    0.70%
  • 43

    Replimune Group Inc Com

    REPLHealth Care
    0.70%
  • 44

    Tango Therapeutics Inc.

    TNGXHealth Care
    0.68%
  • 45

    Cullinan Oncology Inc

    CGEMHealth Care
    0.67%
  • 46

    Tyra Biosciences Inc

    TYRAHealth Care
    0.66%
  • 47

    Amani Gold Ltd

    ANL:AUUnknown
    0.58%
  • 48

    Syndax Pharmaceuticals Inc

    SNDXHealth Care
    0.50%
  • 49

    Candel Therapeutics Inc.

    CADLHealth Care
    0.46%
  • 50

    Janux Therapeutics Inc

    JANXHealth Care
    0.46%
  • 51

    Bicara Therapeutics, Inc.

    BCAXHealth Care
    0.43%
  • 52

    Olema Pharmaceuticals Inc

    OLMAHealth Care
    0.43%
  • 53

    Cytomx Therapeutics Inc

    CTMXHealth Care
    0.38%
  • 54

    Moderna therapeutics

    MRNAHealth Care
    0.38%
  • 55

    Arvinas Inc

    ARVNHealth Care
    0.37%
  • 56

    First Tracks Biotherapeutics, Inc.

    TRAXUnknown
    0.36%
  • 57

    ARRIVENT BIOPHARMA INC

    AVBPHealth Care
    0.31%
  • 58

    Autolus Therapeutics Ltd. Adr

    AUTL:LNHealth Care
    0.26%
  • 59

    BRIDGEBIO ONCOLOGY THERAPEUTICS IN

    BBOTUnknown
    0.24%